Psychedelics as Catalysts for Human Agency with Matthew W. Johnson, PhD

Psychedelics as Catalysts for Human Agency with Matthew W. Johnson, PhD

Author: Lynn Marie Morski, MD, JD December 4, 2025 Duration: 44:27
Psychedelic Medicine Podcast with Dr. Lynn Marie Morski
HealthHealth & FitnessFitnessMedicineMental

In this episode, Matthew W. Johnson, PhD returns to discuss how psychedelics can be leveraged to catalyze human agency. Dr. Johnson has been at the forefront of psychedelic research for 21 years, having conducted seminal research on the effects of psilocybin on mystical experience, personality, and treatment of cancer distress, major depressive disorder, and tobacco addiction. His work with tobacco addiction received the first federal funding for a classic psychedelic in the modern era of research.

In this conversation, Dr. Johnson explores psychedelics as powerful enhancers of human agency—the felt capacity to steer one's own life, make meaningful choices, and act from a place of inner autonomy. Drawing from two decades of research across depression, cancer distress, addiction, and healthy volunteer studies, he argues that increases in agency may be a core, yet under-recognized, mechanism behind therapeutic change. Dr. Johnson discusses agency as a "meta-executive" function intertwined with free will, mental flexibility, and meaning-making, and suggests that psychedelics may uniquely illuminate and strengthen this capacity. In closing, he shares thoughts on how individuals can better take advantage of psychedelic-induced neuroplasticity to increase agency in their own lives.

 

In this episode, you'll hear:

  • What Dr. Johnson means by "agency" and why he sees it as central to psychedelic healing
  • Clinical examples of participants who rediscovered autonomy, changed behaviors, or reframed their suffering after psilocybin sessions
  • Why psychedelics may enhance big-picture psychological flexibility, not just moment-to-moment cognitive flexibility
  • How increased agency may help people with depression, addiction, and cancer distress shift entrenched patterns of thinking and behavior
  • Potential future research directions for studying the neuroscience of agency

 

Quotes:

"It's not just that enhancing agency is the elephant in the room of why psychedelics are working, it's also that I think psychedelics can be a tool for finally understanding this thing of human agency." [4:31]

"Even if you think the sense of free will is an illusion, it has to be an evolutionarily advantageous illusion. Why else would it be seemingly universal?" [12:30]

"When someone really has one of these 'ah-ha' experiences, they can really come to this perspective of 'no, no, no, no, no, I really am choosing how I'm thinking about myself.' In cancer [patients] it happened a lot." [21:51]

 

Links:

Previous episode: The Latest Research on Psilocybin for Depression with Matthew Johnson, PhD

Previous episode: Exploring DMT Entities with Matthew Johnson, PhD

Previous episode: Avoiding the Pitfalls of Psychedelic Medicine with Matthew Johnson, PhD

Dr. Johnson on X

Dr. Johnson on Instagram
Dr. Johnson on LinkedIn

Psychedelic Medicine Association

Porangui


Exploring the frontier of mind and medicine, the Psychedelic Medicine Podcast with Dr. Lynn Marie Morski delves into the complex world of psychedelic substances and their potential to heal. Hosted by Lynn Marie Morski, a physician and attorney, this podcast navigates the intricate intersection of cutting-edge science, clinical practice, and evolving policy. Each episode brings a grounded, expert perspective to conversations about psilocybin, MDMA, ketamine, LSD, ayahuasca, ibogaine, and other compounds, moving beyond hype to examine the real-world implications of this therapeutic renaissance. Listeners will hear detailed discussions on the latest peer-reviewed research, practical insights from medical professionals integrating these approaches, and thoughtful analysis of the legal landscape shaping access. The dialogue is rooted in a commitment to safety, ethics, and evidence, offering a clear-eyed look at both the profound promise and the challenges inherent in psychedelic medicine. Whether you're a healthcare provider, a patient, a researcher, or simply intellectually curious, this podcast provides an essential, nuanced resource for understanding how these ancient and modern substances are reshaping perspectives on mental health, consciousness, and treatment. It’s a space for serious inquiry, where complex questions about healing, neuroscience, and society are met with informed, accessible conversation.
Author: Language: English Episodes: 100

Official website RSS
instagramlinkedin
Psychedelic Medicine Podcast with Dr. Lynn Marie Morski
Podcast Episodes
Microdosing Psilocybin: Truth vs Hype with Rotem Petranker, PhD [not-audio_url] [/not-audio_url]

Duration: 47:32
In this episode Rotem Petranker, PhD joins to discuss the current state of research on microdosing psilocybin. Dr. Petranker is the co-founder of the Psychedelic Studies Research Program at the University of Toronto and…
Encore Episode: Exploring Endogenous DMT with Rick Strassman, MD [not-audio_url] [/not-audio_url]

Duration: 52:41
In this episode of the Psychedelic Medicine Podcast, Rick Strassman, MD joins to discuss the topic of endogenous DMT. Dr. Strassman is adjunct associate professor of psychiatry at the University of New Mexico in Albuquer…
Psychedelics for Stroke Healing with Steven Zeiler, MD, PhD [not-audio_url] [/not-audio_url]

Duration: 32:57
In this episode Steven Zeiler, MD, PhD joins to discuss the promise of psychedelics for stroke healing. Dr. Zeiler is an associate professor and physician at Johns Hopkins School of Medicine specializing in cerebrovascul…
Long-Term Psychedelic Integration with J. Ashley T. Booth, LCSW, MS [not-audio_url] [/not-audio_url]

Duration: 34:40
In this episode J. Ashley T. Booth, LCSW, MS joins to discuss the importance of long-term psychedelic integration. Ashley is a Los Angeles-based psychedelic therapist, IFS practitioner, and author of Quieting the Storm W…
Is Psilocybin Safe for Me? with Seth Mehr, MD [not-audio_url] [/not-audio_url]

Duration: 52:41
In this episode, Seth Mehr, MD joins to share his expertise on safety planning prior to a patient undergoing psilocybin therapy. After a 20 year career as an Emergency Medicine physician, Seth founded Cascade Psychedelic…

«123456...10»